Literature DB >> 19264776

Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

Jie Liu1, Tracy J Ruckwardt, Man Chen, Teresa R Johnson, Barney S Graham.   

Abstract

CD4 T cells have been shown to play an important role in the immunity and immunopathogenesis of respiratory syncytial virus (RSV) infection. We identified two novel CD4 T-cell epitopes in the RSV M and M2 proteins with core sequences M(213-223) (FKYIKPQSQFI) and M2(27-37) (YFEWPPHALLV). Peptides containing the epitopes stimulated RSV-specific CD4 T cells to produce gamma interferon (IFN-gamma), interleukin 2 (IL-2), and other Th1- and Th2-type cytokines in an I-A(b)-restricted pattern. Construction of fluorochrome-conjugated peptide-I-A(b) class II tetramers revealed RSV M- and M2-specific CD4 T-cell responses in RSV-infected mice in a hierarchical pattern. Peptide-activated CD4 T cells from lungs were more activated and differentiated, and had greater IFN-gamma expression, than CD4 T cells from the spleen, which, in contrast, produced greater levels of IL-2. In addition, M(209-223) peptide-activated CD4 T cells reduced IFN-gamma and IL-2 production in M- and M2-specific CD8 T-cell responses to D(b)-M(187-195) and K(d)-M2(82-90) peptides more than M2(25-39) peptide-stimulated CD4 T cells. This correlated with the fact that I-A(b)-M(209-223) tetramer-positive cells responding to primary RSV infection had a much higher frequency of FoxP3 expression than I-A(b)-M2(26-39) tetramer-positive CD4 T cells, suggesting that the M-specific CD4 T-cell response has greater regulatory function. Characterization of epitope-specific CD4 T cells by novel fluorochrome-conjugated peptide-I-A(b) tetramers allows detailed analysis of their roles in RSV pathogenesis and immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264776      PMCID: PMC2682106          DOI: 10.1128/JVI.02140-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Potential mechanisms causing delayed effects of respiratory syncytial virus infection.

Authors:  P J Openshaw
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

3.  Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.

Authors:  H T Maecker; H S Dunn; M A Suni; E Khatamzas; C J Pitcher; T Bunde; N Persaud; W Trigona; T M Fu; E Sinclair; B M Bredt; J M McCune; V C Maino; F Kern; L J Picker
Journal:  J Immunol Methods       Date:  2001-09-01       Impact factor: 2.303

4.  Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.

Authors:  P J Openshaw; S L Clarke; F M Record
Journal:  Int Immunol       Date:  1992-04       Impact factor: 4.823

5.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

Authors:  S Aung; J A Rutigliano; B S Graham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.

Authors:  Jun Chang; So Young Choi; Hyun Tak Jin; Young Chul Sung; Thomas J Braciale
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  Primary respiratory syncytial virus infection in mice.

Authors:  B S Graham; M D Perkins; P F Wright; D T Karzon
Journal:  J Med Virol       Date:  1988-10       Impact factor: 2.327

9.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.

Authors:  M Connors; A B Kulkarni; C Y Firestone; K L Holmes; H C Morse; A V Sotnikov; B R Murphy
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more
  14 in total

1.  Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses.

Authors:  Benjamin Schwarz; Kaitlyn M Morabito; Tracy J Ruckwardt; Dustin P Patterson; John Avera; Heini M Miettinen; Barney S Graham; Trevor Douglas
Journal:  ACS Biomater Sci Eng       Date:  2016-11-03

3.  Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response.

Authors:  Richard J Betts; Nayana Prabhu; Adrian W S Ho; Fei Chuin Lew; Paul E Hutchinson; Olaf Rotzschke; Paul A Macary; D Michael Kemeny
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

4.  Identification of Novel Respiratory Syncytial Virus CD4+ and CD8+ T Cell Epitopes in C57BL/6 Mice.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  Immunohorizons       Date:  2019-01-14

5.  CD4+ T-cell epitope prediction using antigen processing constraints.

Authors:  Ramgopal R Mettu; Tysheena Charles; Samuel J Landry
Journal:  J Immunol Methods       Date:  2016-02-15       Impact factor: 2.303

6.  Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.

Authors:  Ross B Fulton; David K Meyerholz; Steven M Varga
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

7.  Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.

Authors:  Seyhan Boyoglu-Barnum; Tatiana Chirkova; Sean O Todd; Thomas R Barnum; Kelsey A Gaston; Patricia Jorquera; Lia M Haynes; Ralph A Tripp; Martin L Moore; Larry J Anderson
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

8.  Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.

Authors:  Rhonda C Kines; Vladimir Zarnitsyn; Teresa R Johnson; Yuk-Ying S Pang; Kizzmekia S Corbett; John D Nicewonger; Anu Gangopadhyay; Man Chen; Jie Liu; Mark R Prausnitz; John T Schiller; Barney S Graham
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

9.  MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.

Authors:  Heather M Long; Odette L Chagoury; Alison M Leese; Gordon B Ryan; Eddie James; Laura T Morton; Rachel J M Abbott; Shereen Sabbah; William Kwok; Alan B Rickinson
Journal:  J Exp Med       Date:  2013-04-08       Impact factor: 14.307

Review 10.  The CD4 T cell response to respiratory syncytial virus infection.

Authors:  Allison F Christiaansen; Cory J Knudson; Kayla A Weiss; Steven M Varga
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.